Yeshwant Krishna
SEC insider (Form 3/4/5 filer). CIK 0001585001. Director at Parabilis Medicines, Inc. (PBLS) and 1 other issuer. 7 reported Form 4/5 transactions since Sep 2024; latest on Jun 9, 2026. Located in CAMBRIDGE, MA.
Companies Yeshwant Krishna has filed insider reports for
- Parabilis Medicines, Inc. (PBLS): Director
- Verve Therapeutics, Inc. (VERV): Director, 10% Owner
Yeshwant Krishna
CIK: 0001585001
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (7 total)
- Jun 9, 2026PBLS
Parabilis Medicines, Inc.
AwardDirectStock Option (Right to Buy)
20.2K shares- - Jul 25, 2025VERV
Verve Therapeutics, Inc.
Tender OfferIndirect4.3M shares- - Jul 25, 2025VERV
Verve Therapeutics, Inc.
Tender OfferIndirect1.8M shares- - Jul 25, 2025VERV
Verve Therapeutics, Inc.
Tender OfferIndirect6.1M shares- - Jul 25, 2025VERV
Verve Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
42.2K shares- - Jul 25, 2025VERV
Verve Therapeutics, Inc.
DispositionDirectStock Option (right to buy)
136.1K shares- - Jun 5, 2025VERV
Verve Therapeutics, Inc.
AwardDirectStock Option (right to buy)
42.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 9, 2026 |  PBLS Parabilis Medicines, Inc. | Award Stock Option (Right to Buy) | 20,215 | - | - | Direct |
| Jul 25, 2025 |  VERV Verve Therapeutics, Inc. | Tender Offer | 4,260,047 | - | - | Indirect |
| Jul 25, 2025 | VERV Verve Therapeutics, Inc. | Tender Offer | 1,800,000 | - | - | Indirect |
| Jul 25, 2025 | VERV Verve Therapeutics, Inc. | Tender Offer | 6,108,442 | - | - | Indirect |
| Jul 25, 2025 | VERV Verve Therapeutics, Inc. | Disposition Stock Option (right to buy) | 42,200 | - | - | Direct |
| Jul 25, 2025 | VERV Verve Therapeutics, Inc. | Disposition Stock Option (right to buy) | 136,139 | - | - | Direct |
| Jun 5, 2025 | VERV Verve Therapeutics, Inc. | Award Stock Option (right to buy) | 42,200 | - | - | Direct |
1-7 of 7 transactions